nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—CYP2C9—Vismodegib—skin cancer	0.224	0.481	CbGbCtD
Flecainide—CYP2D6—Vemurafenib—skin cancer	0.162	0.348	CbGbCtD
Flecainide—CYP2C9—Fluorouracil—skin cancer	0.0795	0.171	CbGbCtD
Flecainide—Angina pectoris—Fluorouracil—skin cancer	0.00134	0.0025	CcSEcCtD
Flecainide—Pneumonia—Temozolomide—skin cancer	0.00133	0.00249	CcSEcCtD
Flecainide—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.00132	0.00246	CcSEcCtD
Flecainide—Flushing—Bleomycin—skin cancer	0.00131	0.00245	CcSEcCtD
Flecainide—Body temperature increased—Vemurafenib—skin cancer	0.00131	0.00245	CcSEcCtD
Flecainide—Neuropathy peripheral—Temozolomide—skin cancer	0.0013	0.00243	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00129	0.0024	CcSEcCtD
Flecainide—Deafness—Docetaxel—skin cancer	0.00128	0.00239	CcSEcCtD
Flecainide—Insomnia—Imiquimod—skin cancer	0.00128	0.00239	CcSEcCtD
Flecainide—Hepatic failure—Docetaxel—skin cancer	0.00127	0.00238	CcSEcCtD
Flecainide—Paraesthesia—Imiquimod—skin cancer	0.00127	0.00237	CcSEcCtD
Flecainide—Cardiac failure congestive—Docetaxel—skin cancer	0.00126	0.00236	CcSEcCtD
Flecainide—Dyspnoea—Imiquimod—skin cancer	0.00126	0.00235	CcSEcCtD
Flecainide—Somnolence—Imiquimod—skin cancer	0.00126	0.00235	CcSEcCtD
Flecainide—Photosensitivity reaction—Fluorouracil—skin cancer	0.00125	0.00234	CcSEcCtD
Flecainide—Alopecia—Bleomycin—skin cancer	0.00125	0.00233	CcSEcCtD
Flecainide—Dyspepsia—Imiquimod—skin cancer	0.00124	0.00232	CcSEcCtD
Flecainide—Pneumonia—Fluorouracil—skin cancer	0.00123	0.0023	CcSEcCtD
Flecainide—Decreased appetite—Imiquimod—skin cancer	0.00123	0.00229	CcSEcCtD
Flecainide—Flushing—Dactinomycin—skin cancer	0.00122	0.00228	CcSEcCtD
Flecainide—Gastrointestinal disorder—Imiquimod—skin cancer	0.00122	0.00228	CcSEcCtD
Flecainide—Fatigue—Imiquimod—skin cancer	0.00122	0.00228	CcSEcCtD
Flecainide—Visual disturbance—Docetaxel—skin cancer	0.00121	0.00226	CcSEcCtD
Flecainide—Pain—Imiquimod—skin cancer	0.00121	0.00226	CcSEcCtD
Flecainide—Neuropathy peripheral—Fluorouracil—skin cancer	0.0012	0.00224	CcSEcCtD
Flecainide—Asthenia—Vemurafenib—skin cancer	0.00119	0.00222	CcSEcCtD
Flecainide—Hallucination—Temozolomide—skin cancer	0.00119	0.00221	CcSEcCtD
Flecainide—Hypoaesthesia—Temozolomide—skin cancer	0.00119	0.00221	CcSEcCtD
Flecainide—Pruritus—Vemurafenib—skin cancer	0.00117	0.00219	CcSEcCtD
Flecainide—Alopecia—Dactinomycin—skin cancer	0.00116	0.00217	CcSEcCtD
Flecainide—Feeling abnormal—Imiquimod—skin cancer	0.00116	0.00217	CcSEcCtD
Flecainide—Gastrointestinal pain—Imiquimod—skin cancer	0.00115	0.00216	CcSEcCtD
Flecainide—Visual impairment—Temozolomide—skin cancer	0.00115	0.00215	CcSEcCtD
Flecainide—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.00115	0.00214	CcSEcCtD
Flecainide—Agranulocytosis—Fluorouracil—skin cancer	0.00114	0.00213	CcSEcCtD
Flecainide—Ill-defined disorder—Bleomycin—skin cancer	0.00114	0.00213	CcSEcCtD
Flecainide—Diarrhoea—Vemurafenib—skin cancer	0.00113	0.00212	CcSEcCtD
Flecainide—Urticaria—Imiquimod—skin cancer	0.00112	0.0021	CcSEcCtD
Flecainide—Abdominal pain—Imiquimod—skin cancer	0.00112	0.00209	CcSEcCtD
Flecainide—Body temperature increased—Imiquimod—skin cancer	0.00112	0.00209	CcSEcCtD
Flecainide—Eye disorder—Temozolomide—skin cancer	0.00111	0.00208	CcSEcCtD
Flecainide—Tinnitus—Temozolomide—skin cancer	0.00111	0.00208	CcSEcCtD
Flecainide—Malaise—Bleomycin—skin cancer	0.00111	0.00207	CcSEcCtD
Flecainide—Flushing—Temozolomide—skin cancer	0.00111	0.00207	CcSEcCtD
Flecainide—Leukopenia—Bleomycin—skin cancer	0.0011	0.00206	CcSEcCtD
Flecainide—Dizziness—Vemurafenib—skin cancer	0.00109	0.00205	CcSEcCtD
Flecainide—Hypoaesthesia—Fluorouracil—skin cancer	0.00109	0.00204	CcSEcCtD
Flecainide—Ataxia—Docetaxel—skin cancer	0.00108	0.00201	CcSEcCtD
Flecainide—Immune system disorder—Temozolomide—skin cancer	0.00108	0.00201	CcSEcCtD
Flecainide—Cough—Bleomycin—skin cancer	0.00107	0.002	CcSEcCtD
Flecainide—Ill-defined disorder—Dactinomycin—skin cancer	0.00106	0.00199	CcSEcCtD
Flecainide—Vomiting—Vemurafenib—skin cancer	0.00105	0.00197	CcSEcCtD
Flecainide—Alopecia—Temozolomide—skin cancer	0.00105	0.00197	CcSEcCtD
Flecainide—Chest pain—Bleomycin—skin cancer	0.00105	0.00196	CcSEcCtD
Flecainide—Myalgia—Bleomycin—skin cancer	0.00105	0.00196	CcSEcCtD
Flecainide—Rash—Vemurafenib—skin cancer	0.00104	0.00195	CcSEcCtD
Flecainide—Dermatitis—Vemurafenib—skin cancer	0.00104	0.00195	CcSEcCtD
Flecainide—Headache—Vemurafenib—skin cancer	0.00104	0.00194	CcSEcCtD
Flecainide—Discomfort—Bleomycin—skin cancer	0.00103	0.00193	CcSEcCtD
Flecainide—Malaise—Dactinomycin—skin cancer	0.00103	0.00193	CcSEcCtD
Flecainide—Leukopenia—Dactinomycin—skin cancer	0.00103	0.00192	CcSEcCtD
Flecainide—Dysgeusia—Temozolomide—skin cancer	0.00102	0.0019	CcSEcCtD
Flecainide—Asthenia—Imiquimod—skin cancer	0.00101	0.00189	CcSEcCtD
Flecainide—Confusional state—Bleomycin—skin cancer	0.00101	0.00189	CcSEcCtD
Flecainide—Oedema—Bleomycin—skin cancer	0.001	0.00187	CcSEcCtD
Flecainide—Pruritus—Imiquimod—skin cancer	0.000999	0.00187	CcSEcCtD
Flecainide—Nausea—Vemurafenib—skin cancer	0.000984	0.00184	CcSEcCtD
Flecainide—Thrombocytopenia—Bleomycin—skin cancer	0.000982	0.00184	CcSEcCtD
Flecainide—Vision blurred—Temozolomide—skin cancer	0.000977	0.00183	CcSEcCtD
Flecainide—Myalgia—Dactinomycin—skin cancer	0.000976	0.00182	CcSEcCtD
Flecainide—Bronchospasm—Docetaxel—skin cancer	0.000973	0.00182	CcSEcCtD
Flecainide—Tremor—Temozolomide—skin cancer	0.000971	0.00182	CcSEcCtD
Flecainide—Alopecia—Fluorouracil—skin cancer	0.00097	0.00181	CcSEcCtD
Flecainide—Diarrhoea—Imiquimod—skin cancer	0.000966	0.00181	CcSEcCtD
Flecainide—Discomfort—Dactinomycin—skin cancer	0.000964	0.0018	CcSEcCtD
Flecainide—Angina pectoris—Docetaxel—skin cancer	0.000964	0.0018	CcSEcCtD
Flecainide—Ill-defined disorder—Temozolomide—skin cancer	0.000962	0.0018	CcSEcCtD
Flecainide—Anorexia—Bleomycin—skin cancer	0.000956	0.00179	CcSEcCtD
Flecainide—Hypotension—Bleomycin—skin cancer	0.000937	0.00175	CcSEcCtD
Flecainide—Oedema—Dactinomycin—skin cancer	0.000936	0.00175	CcSEcCtD
Flecainide—Malaise—Temozolomide—skin cancer	0.000935	0.00175	CcSEcCtD
Flecainide—Dizziness—Imiquimod—skin cancer	0.000934	0.00175	CcSEcCtD
Flecainide—Vertigo—Temozolomide—skin cancer	0.000932	0.00174	CcSEcCtD
Flecainide—Leukopenia—Temozolomide—skin cancer	0.000928	0.00173	CcSEcCtD
Flecainide—Palpitations—Temozolomide—skin cancer	0.000916	0.00171	CcSEcCtD
Flecainide—Thrombocytopenia—Dactinomycin—skin cancer	0.000916	0.00171	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000914	0.00171	CcSEcCtD
Flecainide—Cough—Temozolomide—skin cancer	0.000905	0.00169	CcSEcCtD
Flecainide—Paraesthesia—Bleomycin—skin cancer	0.000901	0.00168	CcSEcCtD
Flecainide—Vision blurred—Fluorouracil—skin cancer	0.0009	0.00168	CcSEcCtD
Flecainide—Convulsion—Temozolomide—skin cancer	0.000898	0.00168	CcSEcCtD
Flecainide—Vomiting—Imiquimod—skin cancer	0.000898	0.00168	CcSEcCtD
Flecainide—Hypertension—Temozolomide—skin cancer	0.000895	0.00167	CcSEcCtD
Flecainide—Dyspnoea—Bleomycin—skin cancer	0.000894	0.00167	CcSEcCtD
Flecainide—Anorexia—Dactinomycin—skin cancer	0.000892	0.00167	CcSEcCtD
Flecainide—Rash—Imiquimod—skin cancer	0.00089	0.00166	CcSEcCtD
Flecainide—Dermatitis—Imiquimod—skin cancer	0.00089	0.00166	CcSEcCtD
Flecainide—Pneumonia—Docetaxel—skin cancer	0.000888	0.00166	CcSEcCtD
Flecainide—Headache—Imiquimod—skin cancer	0.000885	0.00165	CcSEcCtD
Flecainide—Arthralgia—Temozolomide—skin cancer	0.000883	0.00165	CcSEcCtD
Flecainide—Myalgia—Temozolomide—skin cancer	0.000883	0.00165	CcSEcCtD
Flecainide—Anxiety—Temozolomide—skin cancer	0.00088	0.00164	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000877	0.00164	CcSEcCtD
Flecainide—Discomfort—Temozolomide—skin cancer	0.000872	0.00163	CcSEcCtD
Flecainide—Decreased appetite—Bleomycin—skin cancer	0.000872	0.00163	CcSEcCtD
Flecainide—Renal failure—Docetaxel—skin cancer	0.000867	0.00162	CcSEcCtD
Flecainide—Neuropathy peripheral—Docetaxel—skin cancer	0.000865	0.00162	CcSEcCtD
Flecainide—Dry mouth—Temozolomide—skin cancer	0.000863	0.00161	CcSEcCtD
Flecainide—Jaundice—Docetaxel—skin cancer	0.00086	0.00161	CcSEcCtD
Flecainide—Pain—Bleomycin—skin cancer	0.000858	0.0016	CcSEcCtD
Flecainide—Leukopenia—Fluorouracil—skin cancer	0.000855	0.0016	CcSEcCtD
Flecainide—Confusional state—Temozolomide—skin cancer	0.000853	0.00159	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000852	0.00159	CcSEcCtD
Flecainide—Oedema—Temozolomide—skin cancer	0.000846	0.00158	CcSEcCtD
Flecainide—Nausea—Imiquimod—skin cancer	0.000839	0.00157	CcSEcCtD
Flecainide—Nervous system disorder—Temozolomide—skin cancer	0.00083	0.00155	CcSEcCtD
Flecainide—Thrombocytopenia—Temozolomide—skin cancer	0.000829	0.00155	CcSEcCtD
Flecainide—Convulsion—Fluorouracil—skin cancer	0.000828	0.00155	CcSEcCtD
Flecainide—Feeling abnormal—Bleomycin—skin cancer	0.000827	0.00155	CcSEcCtD
Flecainide—Agranulocytosis—Docetaxel—skin cancer	0.000823	0.00154	CcSEcCtD
Flecainide—Skin disorder—Temozolomide—skin cancer	0.000822	0.00154	CcSEcCtD
Flecainide—Hyperhidrosis—Temozolomide—skin cancer	0.000818	0.00153	CcSEcCtD
Flecainide—Myalgia—Fluorouracil—skin cancer	0.000813	0.00152	CcSEcCtD
Flecainide—Chest pain—Fluorouracil—skin cancer	0.000813	0.00152	CcSEcCtD
Flecainide—Decreased appetite—Dactinomycin—skin cancer	0.000813	0.00152	CcSEcCtD
Flecainide—Fatigue—Dactinomycin—skin cancer	0.000807	0.00151	CcSEcCtD
Flecainide—Anorexia—Temozolomide—skin cancer	0.000807	0.00151	CcSEcCtD
Flecainide—Discomfort—Fluorouracil—skin cancer	0.000804	0.0015	CcSEcCtD
Flecainide—Pain—Dactinomycin—skin cancer	0.0008	0.0015	CcSEcCtD
Flecainide—Urticaria—Bleomycin—skin cancer	0.000797	0.00149	CcSEcCtD
Flecainide—Body temperature increased—Bleomycin—skin cancer	0.000793	0.00148	CcSEcCtD
Flecainide—Hypoaesthesia—Docetaxel—skin cancer	0.000788	0.00147	CcSEcCtD
Flecainide—Confusional state—Fluorouracil—skin cancer	0.000786	0.00147	CcSEcCtD
Flecainide—Oedema—Fluorouracil—skin cancer	0.00078	0.00146	CcSEcCtD
Flecainide—Feeling abnormal—Dactinomycin—skin cancer	0.000771	0.00144	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000771	0.00144	CcSEcCtD
Flecainide—Insomnia—Temozolomide—skin cancer	0.000765	0.00143	CcSEcCtD
Flecainide—Gastrointestinal pain—Dactinomycin—skin cancer	0.000765	0.00143	CcSEcCtD
Flecainide—Nervous system disorder—Fluorouracil—skin cancer	0.000765	0.00143	CcSEcCtD
Flecainide—Thrombocytopenia—Fluorouracil—skin cancer	0.000763	0.00143	CcSEcCtD
Flecainide—Visual impairment—Docetaxel—skin cancer	0.000763	0.00143	CcSEcCtD
Flecainide—Tachycardia—Fluorouracil—skin cancer	0.000761	0.00142	CcSEcCtD
Flecainide—Paraesthesia—Temozolomide—skin cancer	0.00076	0.00142	CcSEcCtD
Flecainide—Dyspnoea—Temozolomide—skin cancer	0.000754	0.00141	CcSEcCtD
Flecainide—Somnolence—Temozolomide—skin cancer	0.000752	0.00141	CcSEcCtD
Flecainide—Dyspepsia—Temozolomide—skin cancer	0.000745	0.00139	CcSEcCtD
Flecainide—Anorexia—Fluorouracil—skin cancer	0.000743	0.00139	CcSEcCtD
Flecainide—Eye disorder—Docetaxel—skin cancer	0.00074	0.00138	CcSEcCtD
Flecainide—Abdominal pain—Dactinomycin—skin cancer	0.00074	0.00138	CcSEcCtD
Flecainide—Body temperature increased—Dactinomycin—skin cancer	0.00074	0.00138	CcSEcCtD
Flecainide—Decreased appetite—Temozolomide—skin cancer	0.000736	0.00137	CcSEcCtD
Flecainide—Flushing—Docetaxel—skin cancer	0.000735	0.00137	CcSEcCtD
Flecainide—Gastrointestinal disorder—Temozolomide—skin cancer	0.000731	0.00137	CcSEcCtD
Flecainide—Fatigue—Temozolomide—skin cancer	0.00073	0.00136	CcSEcCtD
Flecainide—Hypotension—Fluorouracil—skin cancer	0.000729	0.00136	CcSEcCtD
Flecainide—Pain—Temozolomide—skin cancer	0.000724	0.00135	CcSEcCtD
Flecainide—Constipation—Temozolomide—skin cancer	0.000724	0.00135	CcSEcCtD
Flecainide—Asthenia—Bleomycin—skin cancer	0.00072	0.00135	CcSEcCtD
Flecainide—Immune system disorder—Docetaxel—skin cancer	0.000715	0.00134	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00071	0.00133	CcSEcCtD
Flecainide—Pruritus—Bleomycin—skin cancer	0.00071	0.00133	CcSEcCtD
Flecainide—Insomnia—Fluorouracil—skin cancer	0.000705	0.00132	CcSEcCtD
Flecainide—Paraesthesia—Fluorouracil—skin cancer	0.0007	0.00131	CcSEcCtD
Flecainide—Alopecia—Docetaxel—skin cancer	0.0007	0.00131	CcSEcCtD
Flecainide—Feeling abnormal—Temozolomide—skin cancer	0.000697	0.0013	CcSEcCtD
Flecainide—Dyspnoea—Fluorouracil—skin cancer	0.000695	0.0013	CcSEcCtD
Flecainide—Somnolence—Fluorouracil—skin cancer	0.000693	0.0013	CcSEcCtD
Flecainide—Gastrointestinal pain—Temozolomide—skin cancer	0.000692	0.00129	CcSEcCtD
Flecainide—Dyspepsia—Fluorouracil—skin cancer	0.000686	0.00128	CcSEcCtD
Flecainide—Decreased appetite—Fluorouracil—skin cancer	0.000678	0.00127	CcSEcCtD
Flecainide—Dysgeusia—Docetaxel—skin cancer	0.000675	0.00126	CcSEcCtD
Flecainide—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000673	0.00126	CcSEcCtD
Flecainide—Urticaria—Temozolomide—skin cancer	0.000672	0.00126	CcSEcCtD
Flecainide—Asthenia—Dactinomycin—skin cancer	0.000671	0.00125	CcSEcCtD
Flecainide—Body temperature increased—Temozolomide—skin cancer	0.000669	0.00125	CcSEcCtD
Flecainide—Abdominal pain—Temozolomide—skin cancer	0.000669	0.00125	CcSEcCtD
Flecainide—Pain—Fluorouracil—skin cancer	0.000667	0.00125	CcSEcCtD
Flecainide—Feeling abnormal—Fluorouracil—skin cancer	0.000643	0.0012	CcSEcCtD
Flecainide—Diarrhoea—Dactinomycin—skin cancer	0.00064	0.0012	CcSEcCtD
Flecainide—Vomiting—Bleomycin—skin cancer	0.000638	0.00119	CcSEcCtD
Flecainide—Rash—Bleomycin—skin cancer	0.000633	0.00118	CcSEcCtD
Flecainide—Dermatitis—Bleomycin—skin cancer	0.000632	0.00118	CcSEcCtD
Flecainide—Urticaria—Fluorouracil—skin cancer	0.000619	0.00116	CcSEcCtD
Flecainide—Syncope—Docetaxel—skin cancer	0.000618	0.00116	CcSEcCtD
Flecainide—Leukopenia—Docetaxel—skin cancer	0.000617	0.00115	CcSEcCtD
Flecainide—Body temperature increased—Fluorouracil—skin cancer	0.000616	0.00115	CcSEcCtD
Flecainide—Palpitations—Docetaxel—skin cancer	0.000609	0.00114	CcSEcCtD
Flecainide—Asthenia—Temozolomide—skin cancer	0.000607	0.00113	CcSEcCtD
Flecainide—Loss of consciousness—Docetaxel—skin cancer	0.000606	0.00113	CcSEcCtD
Flecainide—Cough—Docetaxel—skin cancer	0.000602	0.00112	CcSEcCtD
Flecainide—Pruritus—Temozolomide—skin cancer	0.000599	0.00112	CcSEcCtD
Flecainide—Convulsion—Docetaxel—skin cancer	0.000597	0.00112	CcSEcCtD
Flecainide—Nausea—Bleomycin—skin cancer	0.000596	0.00111	CcSEcCtD
Flecainide—Hypertension—Docetaxel—skin cancer	0.000595	0.00111	CcSEcCtD
Flecainide—Vomiting—Dactinomycin—skin cancer	0.000595	0.00111	CcSEcCtD
Flecainide—Rash—Dactinomycin—skin cancer	0.00059	0.0011	CcSEcCtD
Flecainide—Myalgia—Docetaxel—skin cancer	0.000587	0.0011	CcSEcCtD
Flecainide—Chest pain—Docetaxel—skin cancer	0.000587	0.0011	CcSEcCtD
Flecainide—Arthralgia—Docetaxel—skin cancer	0.000587	0.0011	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000583	0.00109	CcSEcCtD
Flecainide—Diarrhoea—Temozolomide—skin cancer	0.000579	0.00108	CcSEcCtD
Flecainide—Dry mouth—Docetaxel—skin cancer	0.000574	0.00107	CcSEcCtD
Flecainide—Confusional state—Docetaxel—skin cancer	0.000567	0.00106	CcSEcCtD
Flecainide—Oedema—Docetaxel—skin cancer	0.000563	0.00105	CcSEcCtD
Flecainide—Dizziness—Temozolomide—skin cancer	0.00056	0.00105	CcSEcCtD
Flecainide—Nausea—Dactinomycin—skin cancer	0.000556	0.00104	CcSEcCtD
Flecainide—Shock—Docetaxel—skin cancer	0.000554	0.00103	CcSEcCtD
Flecainide—Nervous system disorder—Docetaxel—skin cancer	0.000552	0.00103	CcSEcCtD
Flecainide—Pruritus—Fluorouracil—skin cancer	0.000552	0.00103	CcSEcCtD
Flecainide—Thrombocytopenia—Docetaxel—skin cancer	0.000551	0.00103	CcSEcCtD
Flecainide—Tachycardia—Docetaxel—skin cancer	0.000549	0.00103	CcSEcCtD
Flecainide—Skin disorder—Docetaxel—skin cancer	0.000547	0.00102	CcSEcCtD
Flecainide—Vomiting—Temozolomide—skin cancer	0.000538	0.00101	CcSEcCtD
Flecainide—Anorexia—Docetaxel—skin cancer	0.000536	0.001	CcSEcCtD
Flecainide—Rash—Temozolomide—skin cancer	0.000534	0.000997	CcSEcCtD
Flecainide—Diarrhoea—Fluorouracil—skin cancer	0.000533	0.000997	CcSEcCtD
Flecainide—Dermatitis—Temozolomide—skin cancer	0.000533	0.000996	CcSEcCtD
Flecainide—Headache—Temozolomide—skin cancer	0.00053	0.000991	CcSEcCtD
Flecainide—Hypotension—Docetaxel—skin cancer	0.000526	0.000983	CcSEcCtD
Flecainide—Dizziness—Fluorouracil—skin cancer	0.000516	0.000964	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000513	0.000958	CcSEcCtD
Flecainide—Insomnia—Docetaxel—skin cancer	0.000509	0.000951	CcSEcCtD
Flecainide—Paraesthesia—Docetaxel—skin cancer	0.000505	0.000944	CcSEcCtD
Flecainide—Nausea—Temozolomide—skin cancer	0.000503	0.000939	CcSEcCtD
Flecainide—Dyspnoea—Docetaxel—skin cancer	0.000502	0.000938	CcSEcCtD
Flecainide—Somnolence—Docetaxel—skin cancer	0.0005	0.000935	CcSEcCtD
Flecainide—Vomiting—Fluorouracil—skin cancer	0.000496	0.000927	CcSEcCtD
Flecainide—Dyspepsia—Docetaxel—skin cancer	0.000495	0.000926	CcSEcCtD
Flecainide—Rash—Fluorouracil—skin cancer	0.000492	0.000919	CcSEcCtD
Flecainide—Dermatitis—Fluorouracil—skin cancer	0.000491	0.000918	CcSEcCtD
Flecainide—Decreased appetite—Docetaxel—skin cancer	0.000489	0.000914	CcSEcCtD
Flecainide—Headache—Fluorouracil—skin cancer	0.000488	0.000913	CcSEcCtD
Flecainide—Gastrointestinal disorder—Docetaxel—skin cancer	0.000486	0.000908	CcSEcCtD
Flecainide—Fatigue—Docetaxel—skin cancer	0.000485	0.000907	CcSEcCtD
Flecainide—Pain—Docetaxel—skin cancer	0.000481	0.000899	CcSEcCtD
Flecainide—Constipation—Docetaxel—skin cancer	0.000481	0.000899	CcSEcCtD
Flecainide—Feeling abnormal—Docetaxel—skin cancer	0.000464	0.000867	CcSEcCtD
Flecainide—Nausea—Fluorouracil—skin cancer	0.000463	0.000866	CcSEcCtD
Flecainide—Gastrointestinal pain—Docetaxel—skin cancer	0.00046	0.00086	CcSEcCtD
Flecainide—Abdominal pain—Docetaxel—skin cancer	0.000445	0.000831	CcSEcCtD
Flecainide—Body temperature increased—Docetaxel—skin cancer	0.000445	0.000831	CcSEcCtD
Flecainide—Asthenia—Docetaxel—skin cancer	0.000404	0.000755	CcSEcCtD
Flecainide—Pruritus—Docetaxel—skin cancer	0.000398	0.000744	CcSEcCtD
Flecainide—Diarrhoea—Docetaxel—skin cancer	0.000385	0.00072	CcSEcCtD
Flecainide—Dizziness—Docetaxel—skin cancer	0.000372	0.000696	CcSEcCtD
Flecainide—Vomiting—Docetaxel—skin cancer	0.000358	0.000669	CcSEcCtD
Flecainide—Rash—Docetaxel—skin cancer	0.000355	0.000663	CcSEcCtD
Flecainide—Dermatitis—Docetaxel—skin cancer	0.000355	0.000663	CcSEcCtD
Flecainide—Headache—Docetaxel—skin cancer	0.000353	0.000659	CcSEcCtD
Flecainide—Nausea—Docetaxel—skin cancer	0.000334	0.000625	CcSEcCtD
